Foghorn Therapeutics Inc. (FHTX) stock
FHTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/301% below fair value
$2.07+0.02 (+0.98%)
Close on Nov 13, 2026Market cap $122.93MP/E 29.6Yield –
Foghorn Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Foghorn Therapeutics's price to book ratio was 14.8× on Jan 31, 2023, against 7.0× a year earlier. Over the last 2 years it ranged from 2.7× to 14.8×, with a median of 6.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jan 31, 2023 | 14.8× | +3.8 |
| 2022 | Dec 30, 2022 | 11.0× | +0.5 |
| 2021 | Dec 31, 2021 | 10.5× | – |
See a number that looks wrong?